Skip to main content
Log in

Vascular applications of human gene therapy

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Summary

Complexing recombinant DNA with cationic liposomes is a convenient means of introducing foreign genes into cells (lipofection) and could potentially form the basis for genetically modifying diseased blood vessels in patients. The mechanism of lipofection is incompletely understood, but it is recognized that the degree of successful gene transfer is highly dependent on cell type. We have transfected primary cultures of human vascular smooth muscle cells with a plasmid expressing either firefly luciferase (Luc) or nuclearlocalized β-galactosidase (NL-β-gal). Cells were derived from either normal human internal mammary arteries, fragments of primary atherosclerotic plaque, or fragments of restenotic lesion. Concurrent lipofection of rabbit vascular smooth muscle cells and NIH 3T3 cells was performed as well. Compared with NIH 3T3 cells, expression in human vascular smooth muscle cells was markedly reduced: In cells derived from internal mammary artery, Luc expression, normalized for protein content, was 123-fold lower than in NIH 3T3 cells, while the proportion of cells expressing NL-β-gal was 30-fold lower. Luc expression in cells derived from restenotic tissue was significantly greater than from cells derived from primary plaque. Within a given population of cells, the mitotic index of cells expressing the recombinant gene was significantly higher than the mitotic index for the total population of cells (p < 0.05). Finally, cotransfection experiments, in which lipofection of smooth muscle cells was performed using genes for NL-β-gal and for human growth hormone, showed that among positive transfectants a high proportion of cells (23–36%) coexpressed both genes. Thus, the efficiency of successful lipofection in human vascular smooth muscle cells in vitro is low. Transfection appears to be preferentially facilitated in cells derived from restenotic tissue and specific properties of smooth muscle cells, including growth rates, appear to be critical for successful transfection. Further elucidation of cell properties that promote transfection is required to augment the efficiency of liposome-mediated gene transfer in human vascular cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Nabel EG, Plautz G, Boyce FM, Stanley JC, Nabel GJ. Recombinant gene expression in vivo within endothelial cells of the arterial wall.Science 1989;244:1342–1344.

    PubMed  Google Scholar 

  2. Plautz G, Nabel EG, Nabel GJ. Introduction of vascular smooth muscle cells expressing recombinant genes in vivo.Circulation 1991;83:578–583.

    PubMed  Google Scholar 

  3. Lynch CM, Clowes MM, Osborne WRA, Clowes AW, Miller AD. Long-term expression of human adenosine deaminase in vascular smooth muscle cells of rats: A model for gene therapy.Proc Natl Acad Sci USA 1992;89:1138–1142.

    PubMed  Google Scholar 

  4. Nabel EG, Plautz G, Nabel GJ. Site-specific gene expression in vivo by direct gene transfer into the arterial wall.Science 1990;249:1285–1288.

    PubMed  Google Scholar 

  5. Lim CS, Chapman GD, Gammon RS, Muhlestein JB, Bauman RP, Stack RS, Swain JL. Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog.Circulation 1991;83:2007–2011.

    PubMed  Google Scholar 

  6. Flugelman MY, Jaklitsch MT, Newman KD, Cascells W, Bratthauer GL, Dichek DA. Low level in vivo gene transfer into the arterial wall through a perforated balloon catheter.Circulation 1992;85:1110–1117.

    PubMed  Google Scholar 

  7. Nabel EG, Plautz G, Nabel GJ. Transduction of foreign histocompatibility gene into the arterial wall induces vasculitis.Proc Natl Acad Sci USA 1992;89:5157–5161.

    PubMed  Google Scholar 

  8. Leclerc G, Gal D, Takeshita S, Nikol S, Weir L, Isner JM. Percutaneous arterial gene transfer in a rabbit model: Efficiency in normal and balloon-dilated atherosclerotic arteries.J Clin Invest 1992;90:936–944.

    PubMed  Google Scholar 

  9. Ross R. The pathogenesis of atherosclerosis-an updateN Engl J Med 1986;314:488–500.

    PubMed  Google Scholar 

  10. Fuster V, Badimon L, Badiman J, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (first of two parts).N Engl J Med 1992;326:242–250.

    PubMed  Google Scholar 

  11. Felgner PL, Gadak TR, Holm M, et al. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure.Proc Natl Acad Sci USA 1987;84:7413–7417.

    PubMed  Google Scholar 

  12. Felgner PL, Ringold GM. Cationic liposome-mediated transfection.Nature 1989;337:387–388.

    PubMed  Google Scholar 

  13. Stamatatos L, Leventis R, Zuckermann MJ, Silvius JR. Interactions of cationic lipid vesicles with negatively charged phospholipid vesicles and biological membranes.Biochemistry 1988;27:3917–3925.

    PubMed  Google Scholar 

  14. Holt CE, Garlick N, Cornel E. Lipofection of cDNAs in the embryonic vertebrate central nervous system.Neuron 1990;4:203–214.

    PubMed  Google Scholar 

  15. Leventis R, Silvius JR. Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles.Biochim Biophys Acta 1990;1023:124–132.

    PubMed  Google Scholar 

  16. Pickering JG, Jekanowski J, Weir L, Takeshita S, Losordo DW, Isner JM. Liposome-mediated gene transfer into human vascular smooth muscle cells.Circulation 1994;89:13–21.

    PubMed  Google Scholar 

  17. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K.Current Protocols in Molecular Biology. New York: John Wiley and Sons, 1989:9.1–9.14.

    Google Scholar 

  18. Wu GY, Wu CH. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system.J Biol Chem 1987; 262:4429–4434.

    PubMed  Google Scholar 

  19. Zenke M, Steinlein P, Wagner E, Cotten M, Beug H, Birnstiel ML. Receptor-mediated endocytosis of transferrinpolycation conjugates: An efficient way to introduce DNA into hematopoietic cells.Proc Natl Acad Sci 1990;87:3655–3659.

    PubMed  Google Scholar 

  20. Wagner EL, Zatloukal K, Cotten M, Kirlappos H, Mechtler K, Curiel DT, Birnsteil ML. Coupling of adenovirus to transferring-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes.Proc Natl Acad Sci USA 1992;89:6099–6103.

    PubMed  Google Scholar 

  21. Nabel EG, Plautz G, Nabel GJ. Gene transfer into vascular cells.J Am Coll Cardiol 1991;17:189B-194B.

    PubMed  Google Scholar 

  22. Fuerst TR, Niles EG, Studier RW, Moss B: Eukaryotic transient expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.Proc Natl Acad Sci USA 1986;83:8122–8126.

    PubMed  Google Scholar 

  23. Nicolau C, Sene C: Liposome-mediated DNA transfer in eukaryotic cells. Dependence of the transfer efficiency upon the type of liposome used and the host cell cycle stage.Biochim Biophys Acta 1982;721:185–190.

    PubMed  Google Scholar 

  24. Takeshita S, Leclerc G, Weir L, Isner JM. Arterial gene transfer: Effect of cell proliferation on transfection efficiency.Circulation 1992;86:I-228.

    Google Scholar 

  25. Takeshita S, Gal D, Leclerc G, Pickering JG, Riessen R, Weir L, Isner JM. Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation.J Clin Invest 1994;93:652–661.

    PubMed  Google Scholar 

  26. Dartsch PC, Voisard R, Bauriedel G, Hofling B, Betz E. Growth characteristics and cytoskeletal organization of cultured smooth muscle cells from human primary stenosing and restenosing lesions.Arteriosclerosis 1990;10:62–75.

    PubMed  Google Scholar 

  27. Pickering JG, Weir L, Jekanowski J, Kearney M, Isner JM. Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization.J Clin Invest 1993;91:1469–1480.

    PubMed  Google Scholar 

  28. Nabel EG, Yang ZY, Plautz G, et al. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo.Nature 1993;362:844–846.

    PubMed  Google Scholar 

  29. Nabel EG, Yang Z, Liptay S, San H, Gordon D, Haudenschild CC, Nabel GJ. Recombinant platelet-derived growth factor B gene expression in porcine arteries induces intimal hyperplasia in vivo.J Clin Invest 1993;91:1822–1829.

    PubMed  Google Scholar 

  30. Losordo DW, Pickering G, Takeshita S, et al. Use of the rabbit ear artery to serially assess foreign protein secretion after site-specific arterial gene transfer in vivo: Evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene expression.Circulation 1994;89:785–792.

    PubMed  Google Scholar 

  31. Steg PG, Feldman LJ, Scoazec J-Y et al. Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector.Circulation 1994;90:1648–1656.

    PubMed  Google Scholar 

  32. Schneider MD, French BA. The advent of adenovirus. Gene therapy for cardiovascular disease.Circulation 1993;88:1937–1942.

    PubMed  Google Scholar 

  33. Barr E, Leiden JM. Somatic gene therapy for cardiovascular disease: Recent advances.Trends Cardiovasc Med 4:57–63, 1994.

    Google Scholar 

  34. Stewart MJ, Plautz GE, DelBuono L, et al. Gene transfer in vivo with DNA-liposome complexes: Safety and acute toxicity in mice.Hum Gene Therapy 1992;3:267–275.

    Google Scholar 

  35. Nabel EG, Gordon D, Yang ZY, et al. Gene transfer in vivo with DNA-liposome complexes: Lack of autoimmunity and gonadal localization.Hum Gene Therapy 1992;649–656.

  36. Ishikawa Y, Homey CJ. High efficiency gene transfer into mammalian cells by a double transfection protocol.Nucleic Acids Res 1992;20:4367.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported in part by grants from the National Heart, Lung, and Blood Institute (HL40518, HL02824 (JMI)] and the John and Cora Davis Foundation, Washington, D.C. Research was performed during Dr. Pickering's tenure as a Research Fellow of the Medical Research Council of Canada.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pickering, J.G., Takeshita, S., Feldman, L. et al. Vascular applications of human gene therapy. J Thromb Thrombol 1, 299–302 (1995). https://doi.org/10.1007/BF01060740

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01060740

Key words

Navigation